Search for: "SEC v. Peters" Results 1 - 20 of 327
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Mar 2024, 6:30 am
Posted by Georgia Stewart, Tumelo, on Tuesday, February 27, 2024 Tags: ESG, ExxonMobil, Proxy voting, shareholder engagement, Shareholder power 2024 Proxy Season Preview: Looking for a Silver Lining Posted by Merel Spierings, The Conference Board, on Tuesday, February 27, 2024 Tags: Compensation committees, disclosures, pass-through voting, Proxy season, Say on pay, Shareholder proposals Tornetta v. [read post]
1 Mar 2024, 6:30 am
Posted by Georgia Stewart, Tumelo, on Tuesday, February 27, 2024 Tags: ESG, ExxonMobil, Proxy voting, shareholder engagement, Shareholder power 2024 Proxy Season Preview: Looking for a Silver Lining Posted by Merel Spierings, The Conference Board, on Tuesday, February 27, 2024 Tags: Compensation committees, disclosures, pass-through voting, Proxy season, Say on pay, Shareholder proposals Tornetta v. [read post]
17 Dec 2023, 6:30 am
On November 20, 2023, a federal district court denied summary judgment for the defendant in SEC v. [read post]
17 Dec 2023, 6:30 am
On November 20, 2023, a federal district court denied summary judgment for the defendant in SEC v. [read post]
27 Nov 2023, 6:21 am by centerforartlaw
So this was different from the troop of Charles V, Holy Roman Emperor, looting during the 16th century. [read post]
24 Oct 2023, 9:01 pm by renholding
The SEC’s Whistleblower Program is a critical part of our enforcement efforts. [read post]
14 Aug 2023, 5:36 am by Guest Author
This paper is much narrower—Sunstein is really unpacking some of the conservative SCOTUS bloc’s internal debates about the MQD in Biden v. [read post]
13 Jul 2023, 12:06 pm by Legal Aggregate
Supreme Court amicus brief they filed, along with scholars Christopher DeMuth and Peter Wallison, in Biden v. [read post]
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
13 Feb 2023, 5:59 am by Kevin LaCroix
[v] The court also considered Delaware’s strong interest in providing a forum for disputes regarding the internal affairs of LLCs formed under its laws. [read post]
10 Feb 2023, 4:44 am by admin
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
31 Oct 2022, 1:13 am by Frank Cranmer
The objections were drawn to the attention of Peter Duthie, the defender’s Chief Executive Officer and, after consulting Glasgow City Council, the SEC’s board unilaterally cancelled the letting. [read post]